Companies Dominating the Exosomes Landscape
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- System Biosciences
- Lonza Group Ltd
- Danaher Corporation
- Bio-Techne Corporation
- RoosterBio, Inc.
- Global Stem Cells Group
- QIAGEN N.V.
- Miltenyi Biotech Technology & Trading Co., Ltd.
- Clara Biotech
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Exosomes Market in 2025 is estimated at USD 220.77 million.
The global market size was valued at over USD 180.25 million in 2024 and is expected to expand at a CAGR of around 28.1%, surpassing USD 4.51 billion revenue by 2037.
North America is poised to exceed USD 1.53 billion by 2037, fueled by superior healthcare systems and government-funded cancer research.
The major players in the market include System Biosciences, Lonza Group Ltd, Danaher Corporation, Bio-Techne Corporation, RoosterBio, Inc., Global Stem Cells Group, QIAGEN N.V., Miltenyi Biotech Technology & Trading Co., Ltd.
